Matthew W. Doust - Concepedia

Author

Matthew W. Doust

Millennium Pain Center

Also Known As

Macaya Douoguih, Mary Bailey, Matthew Doust, Matthew W. Doust, Sandra Kelman

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Millennium Pain Center Carolinas Pain Institute Coastal Orthopedics Atrium Health Wake Forest Baptist Janssen (Belgium)

About

Matthew W. Doust is an author at Millennium Pain Center specializing in vaccination, immunology, and vaccine safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	84
2	Immunology	1	1	84
3	Vaccine Development	1	1	84
4	Covid-19	1	1	84
5	Vaccination	1	1	84

Matthew W. Doust

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain Leonardo Kapural, Cong Yu, Matthew W. Doust, Anesthesiology	2015	796
Comparison of 10-kHz High-Frequency and Traditional Low-Frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain Leonardo Kapural, Cong Yu, Matthew W. Doust, Neurosurgery	2016	449
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial Karin Hardt, An Vandebosch, Jerald Sadoff, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyVaccine Testing	2022	84
Long-term quality of life improvement for chronic intractable back and leg pain patients using spinal cord stimulation: 12-month results from the SENZA-RCT Kasra Amirdelfan, Cong Yu, Matthew W. Doust, Quality of Life Research	2018	71
Evaluation of direct-to-consumer low-volume lab tests in healthy adults Brian Kidd, Gabriel E. Hoffman, Noah Zimmerman, Journal of Clinical Investigation	2016	37
Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial M. Turner, Athanasia Papadimitriou, Peter Winkle, Human Vaccines & Immunotherapeutics	2020	29
Risk of COVID-19 after natural infection or vaccination Anne-Marie Rick, Matthew B. Laurens, Ying Huang, EBioMedicine	2023	13

Page 1